- Home
- TRDA vs CMP Comparison
TRDA vs CMP Comparison
Compare TRDA & CMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRDA
- CMP
- Stock Information
- Founded
- TRDA 2016
- CMP 1993
- Country
- TRDA United States
- CMP United States
- Employees
- TRDA N/A
- CMP N/A
- Industry
- TRDA Biotechnology: Pharmaceutical Preparations
- CMP Other Metals and Minerals
- Sector
- TRDA Health Care
- CMP Basic Materials
- Exchange
- TRDA Nasdaq
- CMP Nasdaq
- Market Cap
- TRDA 609.7M
- CMP 614.7M
- IPO Year
- TRDA 2021
- CMP 2003
- Fundamental
- Price
- TRDA $18.70
- CMP $12.60
- Analyst Decision
- TRDA Strong Buy
- CMP Buy
- Analyst Count
- TRDA 3
- CMP 4
- Target Price
- TRDA $23.33
- CMP $31.00
- AVG Volume (30 Days)
- TRDA 105.0K
- CMP 686.2K
- Earning Date
- TRDA 11-05-2024
- CMP 12-16-2024
- Dividend Yield
- TRDA N/A
- CMP 1.18%
- EPS Growth
- TRDA N/A
- CMP N/A
- EPS
- TRDA 1.55
- CMP N/A
- Revenue
- TRDA $215,232,000.00
- CMP $1,117,400,000.00
- Revenue This Year
- TRDA $47.45
- CMP N/A
- Revenue Next Year
- TRDA N/A
- CMP $7.72
- P/E Ratio
- TRDA $11.61
- CMP N/A
- Revenue Growth
- TRDA 146.92
- CMP N/A
- 52 Week Low
- TRDA $11.35
- CMP $7.51
- 52 Week High
- TRDA $21.79
- CMP $27.10
- Technical
- Relative Strength Index (RSI)
- TRDA 48.30
- CMP 46.12
- Support Level
- TRDA $17.26
- CMP $11.41
- Resistance Level
- TRDA $21.79
- CMP $13.58
- Average True Range (ATR)
- TRDA 0.88
- CMP 0.84
- MACD
- TRDA -0.29
- CMP -0.23
- Stochastic Oscillator
- TRDA 34.03
- CMP 43.07
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.
About CMP Compass Minerals Intl Inc
Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Canada, the us state of Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.